Nevro
IPO
True innovation that transforms more lives
- Headquarters
- Redwood City, California
- Employees
- 1001–5000
- Founded
- 2006
- Business Model
- B2B
- Website
- nevro.com
- Total Funding
- $126.0M
- Last Round
- $48.0M Series CMar 2013
About
Nevro is a medical device company and creator of HFX, an evidence-based spinal cord stimulation system for chronic pain of the trunk and limbs. Its proprietary 10 kHz Therapy is the most studied SCS therapy in the market, providing significant pain relief without paresthesia. The HFX iQ system integrates AI-driven adaptive therapy with cloud data insights for personalized, long-term relief.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account